Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Has anyone successfully used Dara and Dex as first line treatment? Does blood type play into any treatment decsions?

A MyMyelomaTeam Member asked a question 💭
California, CA

Diagnosed as IgA, kappa 20% BMB & High Risk - deletion 17p

October 3, 2024
 · 
Reactions
A MyMyelomaTeam Member

I highly recommend Dr Brandy’s book “Beat Back Cancer Naturally “. Dr Brandy has MM and is doing very well by changing his diet and taking supplements.
Paula🌹

October 3, 2024
A MyMyelomaTeam Member

Hi Katherine,
Have you been diagnosed as Smoldering or MM? I am IgA Kappa with 20% bad plasma and t(14;16). 16q deletion, Monosomy 13 and +5. Since I am only 20% I am Smoldering. I have never heard that blood type matters. It might, but I haven’t come across any research on it.
Paula🌹

October 3, 2024
MyMyelomaTeam

Has anyone successfully used Dara and Dex as first-line treatment?

- Daratumumab (Dara) and dexamethasone (Dex) are commonly used in treating multiple myeloma. Daratumumab is a monoclonal antibody that targets the CD38 protein on myeloma cells, helping the immune system fight the cancer. It has been a breakthrough in Show Full Answer

Has anyone successfully used Dara and Dex as first-line treatment?

- Daratumumab (Dara) and dexamethasone (Dex) are commonly used in treating multiple myeloma. Daratumumab is a monoclonal antibody that targets the CD38 protein on myeloma cells, helping the immune system fight the cancer. It has been a breakthrough in myeloma treatment and is often used in combination with other drugs.

Does blood type play into any treatment decisions?

- Blood type does not typically influence treatment decisions for multiple myeloma. Treatment choices are more often based on factors like genetic markers (e.g., deletion 17p), the type of myeloma (e.g., IgA, kappa), and the patient's overall health and response to previous treatments.

Diagnosed as IgA, kappa 20% BMB & high risk - deletion 17p

- Being diagnosed with IgA, kappa myeloma and having high-risk features like deletion 17p can influence treatment decisions. High-risk genetic markers may lead doctors to choose more aggressive or combination therapies to manage the disease effectively.

October 3, 2024

Related Questions

View All

How is your dexamethasone prescribed?

A MyMyelomaTeam Member asked a question 💭
Warrenton, VA
October 6, 2023

Anyone else have EMP of the orbit without signs of MM?

A MyMyelomaTeam Member asked a question 💭
Oroville, WA
July 2, 2025

Myeloma Treatment Journey: From First Line to Fourth Line
8 Refractory Myeloma Therapies: Know Your Treatment Options
First Myeloma Relapse: What To Expect When Your Initial Treatment Stops Working